Osteonecrosis of jaw after antiangiogenic agent administration in a renal cell carcinoma patient
A 62-year-old patient had characteristics corresponding to the diagnostic criteria of medication-related osteonecrosis of the jaw (MRONJ). She had been treated for renal cell carcinoma with radical nephrectomy and chemotherapy with pazopanib (Votrient®) and everolimus (Afinitor®) antiangiogenic agen...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2017-06-01
|
| Series: | Oral and Maxillofacial Surgery Cases |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S221454191730010X |